Lorence H. Kim's Net Worth
$140 Million
Who is Lorence H. Kim?
Lorence H. Kim has an estimated net worth of $140 Million. This is based on reported shares across multiple companies, which include Moderna, Inc., Seres Therapeutics, Inc., COWEN INC., Revolution Medicines, Inc., and Cencora, Inc..
SEC CIK
Lorence H. Kim's CIK is 0001643746
Past Insider Trading and Trends
2020 was Lorence H. Kim's most active year for acquiring shares with 10 total transactions. Lorence H. Kim's most active month to acquire stocks was the month of May. 2020 was Lorence H. Kim's most active year for disposing of shares, totalling 52 transactions. Lorence H. Kim's most active month to dispose stocks was the month of April. 2019 saw Lorence H. Kim paying a total of $9,467,877.60 for 685,712 shares, this is the most they've acquired in one year. In 2020 Lorence H. Kim cashed out on 2,090,600 shares for a total of $66,934,359.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -0.21% | -2.60K |
$63.80 | -$165,880.00 | 1.22M |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$37.92 | -$9,821,213.37 | 1.2M |
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$32.60 | -$8,932,766.35 | 1.2M |
Scheduled
|
May 27
| ||
Form 4
| -1.64% | -20.00K |
$46.65 | -$18,101,047.60 | 1.2M |
Scheduled
|
May 15 - May 18
| ||
Form 4
|
—
|
0
|
$37.72 | -$12,898,990.02 | 1.22M |
Scheduled
|
May 12
| ||
Form 4
| -1.61% | -20.00K |
$36.21 | -$724,229.67 | 1.22M |
Scheduled
|
Apr 15
| ||
Form 4
| -1.58% | -20.00K |
$26.19 | -$523,819.02 | 1.24M |
Scheduled
|
Mar 16
| ||
Form 4
| -1.56% | -20.00K |
$27.71 | -$554,200.00 | 1.26M |
Scheduled
|
Mar 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| -1.54% | -20.00K |
$28.39 | -$567,817.51 | 1.28M |
Scheduled
|
Feb 25 - Feb 26
| ||
Form 4
| -2.49% | -33.30K |
$23.06 | -$767,782.70 | 1.3M |
Scheduled
|
Feb 7
| ||
Form 4
| -1.82% | -24.70K |
$23.02 | -$568,786.05 | 1.34M |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
| -0.15% | -2.00K |
$23.04 | -$46,080.00 | 1.36M |
Scheduled
|
Jan 22
| ||
Form 4
| +19.27% | 220.18K |
$20.32 | $4,697,687.78 | 1.36M |
Scheduled
|
Dec 6
| ||
Form 4
| -0.44% | -5.00K |
—
|
—
| 1.14M |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +0.04% | 458 |
—
|
—
| 1.15M |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COWEN INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.24K |
$39.00 | -$1,491,204.00 |
0
|
Mar 1
| |||
Form 4
| +27.28% | 8.18K |
—
|
—
| 38.18K |
Aug 30
| |||
Form 4
|
∞
| 30K |
$30.03 | $900,849.00 | 30K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +6.47% | 4.25K |
—
|
—
| 69.95K |
Jun 20
| |||
Form 4
| +7.31% | 4.8K |
—
|
—
| 70.5K |
Jun 20
| |||
Form 4
| +8.60% | 5.2K |
—
|
—
| 65.7K |
Jun 8
| |||
Form 4
| +476.19% | 50K |
$20.00 | $1,000,000.00 | 60.5K |
Jul 22
| |||
Form 4
|
∞
| 10.5K |
—
|
—
| 10.5K |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cencora, Inc. (COR) Snapshot price: $234.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.56% | 843 |
—
|
—
| 2.73K |
Mar 12
| |||
Form 4
| +239.07% | 1.33K |
—
|
—
| 1.89K |
Mar 9
| |||
Form 4
|
∞
| 558 |
—
|
—
| 558 |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |